Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark W Ball

Showing results (161-170 of 170) with videos related to

Pageof 17
Sort By:
You have reached the last page of results.This site can display upto 170 results.
The New England Journal of Medicine|June 18, 2025
Bevacizumab and Erlotinib in Hereditary and Sporadic Papillary Kidney CancerRamaprasad Srinivasan, Sandeep Gurram, Eric A Singer, et al.
Journal of Medical Genetics|September 24, 2024
A novel pathogenic germline chromosome 3 inversion in von Hippel-Lindau diseaseCathy D Vocke, Christopher J Ricketts, Svetlana Pack, et al.
Urologic Oncology|August 23, 2025
Renal surgery following HIF-2α antagonist therapy: Surgical indications, outcomes and growth kineticsDaniel Nethala, Braden Millan, Jason Hyman, et al.
Urology|June 18, 2023
PRDM10 RCC: A Birt-Hogg-Dubé-like Syndrome Associated With Lipoma and Highly Penetrant, Aggressive Renal Tumors Morphologically Resembling Type 2 Papillary Renal Cell CarcinomaLaura S Schmidt, Cathy D Vocke, Christopher J Ricketts, et al.
Brain Research|July 1, 2008
Neurochemical characterization of tyrosine hydroxylase-immunoreactive interneurons in the developing rat cerebral cortexStephen E Asmus, Emily K Anderson, Mark W Ball, et al.
EMBO Molecular Medicine|March 29, 2023
TFEB and TFE3 drive kidney cystogenesis and tumorigenesisChiara Di Malta, Angela Zampelli, Letizia Granieri, et al.
Science (New York, N.Y.)|January 6, 2018
Genomic correlates of response to immune checkpoint therapies in clear cell renal cell carcinomaDiana Miao, Claire A Margolis, Wenhua Gao, et al.
Science Signaling|January 6, 2021
Mitochondrial DNA alterations underlie an irreversible shift to aerobic glycolysis in fumarate hydratase-deficient renal cancerDaniel R Crooks, Nunziata Maio, Martin Lang, et al.
European Urology|September 9, 2025
Defining the Histopathological, Clinical, and Genetic Characteristics of Familial BAP1-associated Renal Cell CarcinomaLina Posada Calderon, Mark T Dawidek, Cerise Tang, et al.
Cancer|August 3, 2021
Genetic risk assessment for hereditary renal cell carcinoma: Clinical consensus statementGennady Bratslavsky, Neil Mendhiratta, Michael Daneshvar, et al.
Pageof 17

Showing results (161-170 of 170) with videos related to

Sort By:
Pageof 17
You have reached the last page of results.This site can display upto 170 results.
The New England Journal of Medicine|June 18, 2025
Bevacizumab and Erlotinib in Hereditary and Sporadic Papillary Kidney CancerRamaprasad Srinivasan, Sandeep Gurram, Eric A Singer, et al.
Journal of Medical Genetics|September 24, 2024
A novel pathogenic germline chromosome 3 inversion in von Hippel-Lindau diseaseCathy D Vocke, Christopher J Ricketts, Svetlana Pack, et al.
Urologic Oncology|August 23, 2025
Renal surgery following HIF-2α antagonist therapy: Surgical indications, outcomes and growth kineticsDaniel Nethala, Braden Millan, Jason Hyman, et al.
Urology|June 18, 2023
PRDM10 RCC: A Birt-Hogg-Dubé-like Syndrome Associated With Lipoma and Highly Penetrant, Aggressive Renal Tumors Morphologically Resembling Type 2 Papillary Renal Cell CarcinomaLaura S Schmidt, Cathy D Vocke, Christopher J Ricketts, et al.
Brain Research|July 1, 2008
Neurochemical characterization of tyrosine hydroxylase-immunoreactive interneurons in the developing rat cerebral cortexStephen E Asmus, Emily K Anderson, Mark W Ball, et al.
EMBO Molecular Medicine|March 29, 2023
TFEB and TFE3 drive kidney cystogenesis and tumorigenesisChiara Di Malta, Angela Zampelli, Letizia Granieri, et al.
Science (New York, N.Y.)|January 6, 2018
Genomic correlates of response to immune checkpoint therapies in clear cell renal cell carcinomaDiana Miao, Claire A Margolis, Wenhua Gao, et al.
Science Signaling|January 6, 2021
Mitochondrial DNA alterations underlie an irreversible shift to aerobic glycolysis in fumarate hydratase-deficient renal cancerDaniel R Crooks, Nunziata Maio, Martin Lang, et al.
European Urology|September 9, 2025
Defining the Histopathological, Clinical, and Genetic Characteristics of Familial BAP1-associated Renal Cell CarcinomaLina Posada Calderon, Mark T Dawidek, Cerise Tang, et al.
Cancer|August 3, 2021
Genetic risk assessment for hereditary renal cell carcinoma: Clinical consensus statementGennady Bratslavsky, Neil Mendhiratta, Michael Daneshvar, et al.
Pageof 17